One Health Group Plc

Net Asset Value • Jun 20, 2023

National Storage Mechanism | Additional information /*<![CDATA[*/ /**/ /**/ /**/ /**/ sup{font-size:80%}link{ color: #0563C1 }visited{ color: #954F72 } .j{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.j{}p.a,li.a,div.a{margin-top:0cm;margin-right:0cm;margin-bottom:8.0pt;margin-left:0cm;line-height:107%;font-size:11.0pt;font-family:"Calibri","sans-serif";} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .j{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /**/ /*]]>*/

RNS Number : 2220D

One Health Group PLC

20 June 2023

Tuesday 20th June 2023

SEAL Advisors issues a review of One Health Group (AQSE: OHGR)

Full year results 2023

One Health Group has reported a strong operational and financial performance in its first year as a listed company. Patients seen and procedures carried out experienced strong growth resulting in revenue and profitability coming in ahead of forecasts. The outlook remains positive, and the company offers an attractive combination of defensive growth at an undemanding valuation.

The full report is available at:

https://www.sealadvisors.com/OHG_SEAL_Oberon_20062023_web.pdf

The report has been sponsored by OHG and does not constitute independent investment research under FCA Handbook rules. No investment activity in OHG's securities is being invited or induced by the publication of this report.

About SEAL Advisors

SEAL provides specialist research services for companies, investment institutions and the legal services industry. All of SEAL's research is bespoke and tailored to the individual needs of its clients. SEAL produces macroeconomic, thematic and issuer-sponsored research. In addition, SEAL provides advice on all aspects of ESG.

For more information see:    www.sealadvisors.com

Contact:                                 research@sealadvisors.com

SEAL Advisors & SEAL Research are trading names of Scott Evans Associates Ltd which is an appointed representative of Messels Ltd which is authorised and regulated by the Financial Conduct Authority

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NEXGZGMVLLZGFZM